Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer
Status:
Active, not recruiting
Trial end date:
2021-01-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if giving lorazepam in combination with
haloperidol can help to control the symptoms of delirium in patients with advanced cancer.
The safety of this drug combination will also be studied.
In this study, lorazepam is being compared to a placebo. A placebo is not a drug. It looks
like the study drug but is not designed to treat any disease or illness. It is designed to be
compared with a study drug to learn if the study drug has any real effect.